End-of-day quote
Shanghai S.E.
06:00:00 2024-05-14 pm EDT
|
5-day change
|
1st Jan Change
|
34.74
CNY
|
-5.42%
|
|
-3.82%
|
-12.45%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,043
|
6,960
|
4,566
|
5,432
|
4,662
|
-
|
-
|
Enterprise Value (EV)
1 |
6,043
|
6,960
|
4,566
|
5,432
|
4,662
|
4,662
|
4,662
|
P/E ratio
|
28.7
x
|
29.1
x
|
18.5
x
|
41.3
x
|
23.8
x
|
15.4
x
|
13.1
x
|
Yield
|
-
|
1.71%
|
-
|
1.13%
|
1.99%
|
2.62%
|
3.63%
|
Capitalization / Revenue
|
-
|
4.56
x
|
3.08
x
|
4.5
x
|
3.14
x
|
2.31
x
|
2.21
x
|
EV / Revenue
|
-
|
4.56
x
|
3.08
x
|
4.5
x
|
3.14
x
|
2.31
x
|
2.21
x
|
EV / EBITDA
|
-
|
19.7
x
|
12
x
|
18.5
x
|
12.3
x
|
6.78
x
|
7.49
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
2.44
x
|
1.55
x
|
1.86
x
|
1.55
x
|
1.44
x
|
1.37
x
|
Nbr of stocks (in thousands)
|
137,556
|
137,556
|
137,132
|
136,893
|
134,184
|
-
|
-
|
Reference price
2 |
43.93
|
50.60
|
33.29
|
39.68
|
34.74
|
34.74
|
34.74
|
Announcement Date
|
2/25/21
|
2/23/22
|
2/26/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,526
|
1,480
|
1,208
|
1,486
|
2,020
|
2,107
|
EBITDA
1 |
-
|
353.3
|
380
|
294.3
|
379
|
688
|
622
|
EBIT
1 |
-
|
272.3
|
275.5
|
147.4
|
219
|
346.5
|
397
|
Operating Margin
|
-
|
17.85%
|
18.61%
|
12.2%
|
14.74%
|
17.15%
|
18.84%
|
Earnings before Tax (EBT)
1 |
-
|
271.4
|
272.1
|
146.8
|
219
|
346.5
|
397
|
Net income
1 |
175.4
|
239.8
|
246.5
|
132.5
|
196
|
308
|
357
|
Net margin
|
-
|
15.72%
|
16.65%
|
10.97%
|
13.19%
|
15.24%
|
16.94%
|
EPS
2 |
1.531
|
1.740
|
1.800
|
0.9600
|
1.460
|
2.260
|
2.650
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.8674
|
-
|
0.4500
|
0.6900
|
0.9100
|
1.260
|
Announcement Date
|
2/25/21
|
2/23/22
|
2/26/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.8%
|
8.67%
|
8.53%
|
4.49%
|
6.51%
|
9.36%
|
10.4%
|
ROA (Net income/ Total Assets)
|
-
|
7.23%
|
-
|
-
|
5.73%
|
7.8%
|
9.01%
|
Assets
1 |
-
|
3,317
|
-
|
-
|
3,421
|
3,949
|
3,962
|
Book Value Per Share
2 |
-
|
20.80
|
21.50
|
21.40
|
22.40
|
24.20
|
25.40
|
Cash Flow per Share
2 |
-
|
1.300
|
1.410
|
3.260
|
2.720
|
3.890
|
3.890
|
Capex
1 |
-
|
406
|
-
|
268
|
274
|
508
|
526
|
Capex / Sales
|
-
|
26.6%
|
-
|
22.18%
|
18.44%
|
25.12%
|
24.96%
|
Announcement Date
|
2/25/21
|
2/23/22
|
2/26/23
|
2/22/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -12.45% | 645M | | +5.75% | 106B | | -3.95% | 63.67B | | +73.81% | 49.32B | | +15.46% | 38.56B | | +5.46% | 32.65B | | +11.59% | 20.08B | | +13.74% | 17.01B | | +20.05% | 15.41B | | +5.02% | 14.41B |
Other Commodity Chemicals
|